HUP0204524A2 - A humán ABC1-gén nukleinsavai és fehérjéi és terápiás és diagnosztikai alkalmazásaik - Google Patents
A humán ABC1-gén nukleinsavai és fehérjéi és terápiás és diagnosztikai alkalmazásaikInfo
- Publication number
- HUP0204524A2 HUP0204524A2 HU0204524A HUP0204524A HUP0204524A2 HU P0204524 A2 HUP0204524 A2 HU P0204524A2 HU 0204524 A HU0204524 A HU 0204524A HU P0204524 A HUP0204524 A HU P0204524A HU P0204524 A2 HUP0204524 A2 HU P0204524A2
- Authority
- HU
- Hungary
- Prior art keywords
- abc1
- acids corresponding
- proteinic
- nucleic
- dysfunction
- Prior art date
Links
- 101150090313 abc1 gene Proteins 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 102100030488 HEAT repeat-containing protein 6 Human genes 0.000 abstract 2
- 101000990566 Homo sapiens HEAT repeat-containing protein 6 Proteins 0.000 abstract 2
- 101000801684 Homo sapiens Phospholipid-transporting ATPase ABCA1 Proteins 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 230000004064 dysfunction Effects 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 108700024394 Exon Proteins 0.000 abstract 1
- 108091092195 Intron Proteins 0.000 abstract 1
- 208000001163 Tangier disease Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000004141 reverse cholesterol transport Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Child & Adolescent Psychology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9907684A FR2795091B1 (fr) | 1999-06-17 | 1999-06-17 | Acides nucleiques et proteines du gene abc1 humain et leur application en therapie et diagnostic |
| US14712899P | 1999-08-04 | 1999-08-04 | |
| PCT/FR2000/001595 WO2000078970A1 (fr) | 1999-06-17 | 2000-06-08 | Acides nucleiques et proteines correspondant au gene abc1 humain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0204524A2 true HUP0204524A2 (hu) | 2003-04-28 |
Family
ID=26234994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0204524A HUP0204524A2 (hu) | 1999-06-17 | 2000-06-08 | A humán ABC1-gén nukleinsavai és fehérjéi és terápiás és diagnosztikai alkalmazásaik |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1190063A1 (ja) |
| JP (1) | JP2003503026A (ja) |
| KR (1) | KR20020012279A (ja) |
| AU (1) | AU5540800A (ja) |
| BR (1) | BR0011724A (ja) |
| CA (1) | CA2375771A1 (ja) |
| HU (1) | HUP0204524A2 (ja) |
| IL (1) | IL147071A0 (ja) |
| MX (1) | MXPA01013062A (ja) |
| NO (1) | NO20016089L (ja) |
| WO (1) | WO2000078970A1 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2367955C (en) | 1999-03-15 | 2009-05-19 | University Of British Columbia | Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| AU2002210636A1 (en) * | 2000-10-31 | 2002-05-15 | Aventis Pharma S.A. | Polymorphic sequences of the human ABCA1 gene, their uses, detection methods and kits |
| FR2815970A1 (fr) * | 2000-10-31 | 2002-05-03 | Aventis Pharma Sa | Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection |
| NZ556415A (en) * | 2002-01-02 | 2009-02-28 | Genentech Inc | Compositions and methods for the diagnosis and treatment of glioma tumor |
| CN112442114A (zh) * | 2019-08-29 | 2021-03-05 | 渥太华Hdl药物研发公司 | 一种多肽及其应用 |
-
2000
- 2000-06-08 EP EP00940477A patent/EP1190063A1/fr not_active Withdrawn
- 2000-06-08 AU AU55408/00A patent/AU5540800A/en not_active Abandoned
- 2000-06-08 IL IL14707100A patent/IL147071A0/xx unknown
- 2000-06-08 BR BR0011724-2A patent/BR0011724A/pt not_active IP Right Cessation
- 2000-06-08 HU HU0204524A patent/HUP0204524A2/hu unknown
- 2000-06-08 WO PCT/FR2000/001595 patent/WO2000078970A1/fr not_active Application Discontinuation
- 2000-06-08 MX MXPA01013062A patent/MXPA01013062A/es unknown
- 2000-06-08 KR KR1020017016224A patent/KR20020012279A/ko not_active Application Discontinuation
- 2000-06-08 JP JP2001505712A patent/JP2003503026A/ja not_active Withdrawn
- 2000-06-08 CA CA002375771A patent/CA2375771A1/fr not_active Abandoned
-
2001
- 2001-12-13 NO NO20016089A patent/NO20016089L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000078970A1 (fr) | 2000-12-28 |
| NO20016089D0 (no) | 2001-12-13 |
| MXPA01013062A (es) | 2002-06-04 |
| IL147071A0 (en) | 2002-08-14 |
| EP1190063A1 (fr) | 2002-03-27 |
| BR0011724A (pt) | 2002-03-26 |
| NO20016089L (no) | 2002-02-15 |
| AU5540800A (en) | 2001-01-09 |
| JP2003503026A (ja) | 2003-01-28 |
| CA2375771A1 (fr) | 2000-12-28 |
| KR20020012279A (ko) | 2002-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kinunel et al. | Tubulin genes of the African trypanosome Trypanosoma brucei rhodesiense: nucleotide sequence of a 3.7-kb fragment containing genes for alpha and beta tubulins | |
| Thim et al. | Tissue-specific processing of cocaine-and amphetamine-regulated transcript peptides in the rat | |
| CA2294516A1 (en) | Ikk-.beta. proteins, nucleic acids and methods | |
| Eggert et al. | Isolation of a Drosophila homolog of the vertebrate homeobox gene Rx and its possible role in brain and eye development | |
| DE69837542D1 (de) | Ldl-rezeptor | |
| Buchman et al. | Molecular biology of circulatory shock. Part II. Expression of four groups of hepatic genes is enhanced after resuscitation from cardiogenic shock. | |
| ATE366814T1 (de) | Gl50 moleküle, sowie verwendungen derselben | |
| WO1989004875A3 (en) | Characterization and detection of sequences associated with autoimmune diseases | |
| EP2298899A3 (en) | CRSP proteins (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor | |
| ATE226216T1 (de) | Netrinrezeptoren | |
| FI900759A0 (fi) | Bukspottskoertelns celloears antigener, vilka erhaollits molekylaer kloning. | |
| WO2000052047A3 (en) | Human dickkopf-related protein and nucleic acid molecules and uses therefor | |
| WO2001000806A3 (en) | Dna's encoding proteins with signal peptides | |
| HUP0204524A2 (hu) | A humán ABC1-gén nukleinsavai és fehérjéi és terápiás és diagnosztikai alkalmazásaik | |
| Maleszka et al. | Data transferability from model organisms to human beings: insights from the functional genomics of the flightless region of Drosophila | |
| CA2294566A1 (en) | Ikk-.alpha. proteins, nucleic acids and methods | |
| WO2000019988A8 (en) | NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF | |
| KR970704887A (ko) | 혈청 파라옥소나제 | |
| EP1208196A4 (en) | NEW SECRETINE FAMILY GPCR TYPE 15571 MOLECULE AND USES THEREOF | |
| Thim | A surprising sequence homology. | |
| Lechtreck et al. | The cruciated microtubule-associated fibers of the green alga Dunaliella bioculata consist of a 31 kDa SF-assemblin | |
| WO2001018216A3 (en) | 26176, a novel calpain protease and uses thereof | |
| WO2002055701A3 (en) | Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof | |
| Kelley | Characterization of isoform diversity among smooth muscle and nonmuscle myosin heavy chains | |
| CA2461199A1 (en) | Atlastin |